Thursday, February 06, 2020 10:38:12 AM
Continued Scientific Peer Reviewed Research.
I post those websites frequently on this board.
Drugs aren't made overnight.
Mipsagargin is not made naturally in a commercially viable supply stream.
https://globaldossier.uspto.gov/#/result/application/US/15100780/289860
European Patent Office:
Communication of intention to grant European Patent 11/21/2019
Application No: 14 835 563.9 - 1111
Ref. W3228 EP
Applicant Phyton Holdings, LLC
U.S. Patent Office
https://portal.uspto.gov/pair/PublicPair
Application Number: 15/100780
PRODUCTION OF THAPSIGARGINS BY THAPSIA CELL SUSPENSION CULTURE
https://www.marketwatch.com/press-release/phyton-biotech-achieves-manufacturing-milestone-with-thapsigargin-the-active-agent-in-mipsagargin-2016-08-22
Phyton BioTech - Phyton’s Plant Cell Fermentation (PCF®) development program that now has begun to define the process by which the Thapsia plant is converted into a preserved, fermentable cell line, thus providing a more sustainable source of high-quality thapsigargin.
Recent RBSH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:19:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:36:33 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM